"Isatin Derivatives as Promising Anti-Inflammatory Agents: A Comprehensive Review of Design, Mechanisms, and Therapeutic Potential”

Abstract

Inflammation is a vital biological response to injury or infection; however, its chronic manifestation is linked to several pathological conditions such as arthritis, cardiovascular disorders, and neurodegenerative diseases. While conventional anti-inflammatory agents, including NSAIDs and corticosteroids, remain mainstays of therapy, their long-term use is often limited by adverse effects and inadequate efficacy. In this context, isatin (1Hindole-2,3-dione) has emerged as a promising scaffold in medicinal chemistry due to its structural versatility and broad pharmacological profile. Numerous isatin derivatives have demonstrated significant anti-inflammatory activity through diverse mechanisms, including inhibition of proinflammatory cytokines (e.g., TNF-α, IL-1β), modulation of COX/LOX enzymes, suppression of NF-κB signaling, and downregulation of nitric oxide (NO) and iNOS expression. Additionally, the antioxidant properties of certain derivatives further enhance their anti-inflammatory potential. Structure-activity relationship (SAR) studies reveal that substitutions at C-5, C-6, and N-1 positions significantly influence biological activity, and hybrid molecules incorporating the isatin nucleus show multi-target capabilities. Advances in synthetic methods, such as microwave-assisted and green chemistry approaches, have facilitated the efficient production of isatin analogs. Preclinical evaluations demonstrate favorable efficacy and safety profiles, with some compounds exhibiting comparable activity to standard NSAIDs. Although clinical data are currently limited, the isatin scaffold holds significant promise for the development of novel, potent, and safer antiinflammatory agents. Future efforts should focus on improving selectivity, bioavailability, and multitarget potential to optimize clinical applicability.